Your browser doesn't support javascript.
loading
Unveiling quality of clinical trial in China: from concern to confirmation.
Huang, Huiyao; Hou, Yiru; Fang, Hong; Xu, Ling; Yu, Yue; Zhang, Huifang; Zhang, Jing; Tang, Yu; Lan, Gongtao; Zhang, Wenbao; Li, Ning.
Afiliación
  • Huang H; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Hou Y; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Fang H; School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, P. R. China.
  • Xu L; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Yu Y; Department of Quality Medicine, Boehringer Ingelheim (China) Investment Co Ltd, Shanghai, P. R. China.
  • Zhang H; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Zhang J; Department of Quality Medicine, Boehringer Ingelheim (China) Investment Co Ltd, Shanghai, P. R. China.
  • Tang Y; Department of Clinical Development Quality, Pfizer Research and Development (China), Beijing, P. R. China.
  • Lan G; Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
  • Zhang W; Department of Drug Registration, National Medical Products Administration, Beijing, P. R. China.
  • Li N; Bureau of Medical Administration, National Health Commission, Beijing, P. R. China.
Cancer Commun (Lond) ; 44(5): 576-579, 2024 May.
Article en En | MEDLINE | ID: mdl-38446523

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article